GenScript

What GenScript does

GenScript Biotech Corporation is a privately held life science research tools and services company founded in 2002 and headquartered in Piscataway, New Jersey, with a cGMP peptide manufacturing facility in Zhenjiang, China. The company provides an integrated portfolio spanning gene synthesis (FLASH Gene, GenBrick up to 200kb), custom peptide synthesis (PepPower, TurboTIDE), recombinant protein and antibody expression (TurboCHO), CRISPR gene editing tools (GenCRISPR, OmniGuide RNA), IVT mRNA and viral vector services (lentivirus, AAV), and clinical-grade cGMP peptide manufacturing for IND-enabling and commercial supply. Its proprietary platforms claim industry-leading turnaround times (5-day peptide synthesis, 5-day lentivirus packaging) and quality metrics (99.99% gene synthesis delivery rate, >98% peptide synthesis success).

The business serves primarily academic and research institutions (Yale, Harvard, Stanford, Columbia, Karolinska, Fred Hutchinson) along with pharmaceutical, biotechnology, cell-and-gene-therapy, and cosmetic-peptide customers through a hybrid direct-to-consumer e-commerce model on genscript.com (with localized CN/JP/EU/KR portals) and an enterprise direct-sales motion for cGMP and large-scale projects. Catalog products (antibodies, ELISA kits, recombinant proteins, precast gels, automated purification systems such as AmMag Quatro) ship next-day; custom and cGMP services are quote-based with multi-year contract options for clinical supply. The portfolio is anchored by ISO 9001:2015 certification, an ISO 27001-compliant information security stack, and a recently opened ICH Q7 / 21 CFR 210/211-compliant manufacturing facility that underwent an Rx-360 audit in March 2025. Bestzyme (enzyme products) and ProBio (CDMO) are operating subsidiaries extending vertical reach into adjacent reagent and contract manufacturing categories.

Name

GenScript

Legal name

GenScript Biotech Corporation

Website

https://genscript.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

GenScript Biotech is a privately held life science tools and services company founded in 2002, offering gene synthesis, peptide/protein services, CRISPR tools, mRNA, viral vectors, and cGMP peptide manufacturing to academic researchers and pharma/biotech customers worldwide.

Ownership category

akta.pro rank

Product category

Biological Research Reagents and Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Gene Therapy CMC/Process Development Platforms (capsid engineering, producer cell lines, plasmids, upstream/downstream) (HLAAACAN)

Keywords

• Gene synthesis services
• Peptide synthesis services
• Protein expression services
• CRISPR gene editing
• Viral vector packaging

Headquarters

HQ city

Piscataway

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Custom Peptide Synthesis Services: Research-grade and cGMP-grade custom peptide synthesis with regular and express delivery options. Quantities from mg to kg scale with >300 available modifications.
2. Gene Synthesis Services: FLASH Gene synthesis and GenBrick large gene synthesis (up to 200kb) services for molecular biology research.
3. Recombinant Protein/Antibody Expression: TurboCHO platform for protein and antibody expression in mammalian, bacterial, and insect systems. Includes bispecific antibody formats.
4. CRISPR Gene Editing Products and Services: gRNA synthesis, Cas nucleases, HDR templates, CRISPR plasmids and libraries for genome editing applications.
5. IVT mRNA and Viral Vector Services: mRNA synthesis including standard, saRNA, and circRNA formats with LNP formulation services. Lentivirus and AAV packaging services for gene therapy applications.
6. Catalog Products: Off-the-shelf reagents including antibodies, ELISA kits, precast gels, recombinant proteins, cell lines, and instruments with next-day shipping.
7. cGMP Peptide Manufacturing: Clinical-grade peptide API manufacturing for IND applications and clinical trials with regulatory affairs support for CMC filing.
8. Catalog Peptides: 200+ in-stock peptides for diabetes research, neuroscience, cosmetics, and other applications with prices ranging from $38 to $15,600.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

GenScript is a life science company that provides custom biological synthesis and engineering services — including gene synthesis, peptide synthesis, recombinant protein and antibody expression, CRISPR gene editing tools, IVT mRNA synthesis, and viral vector (lentivirus/AAV) packaging — alongside a catalog of off-the-shelf reagents and a cGMP peptide manufacturing facility for clinical and commercial supply. The company serves academic, pharmaceutical, biotechnology, and cell/gene therapy customers worldwide through its e-commerce platform and dedicated enterprise sales channels.

Product overview

GenScript is a life science company offering a comprehensive portfolio of biological research products and services organized into major categories: Gene Services (FLASH Gene synthesis, GenBrick long fragment synthesis, cloning), Protein Services (TurboCHO expression kits and services, recombinant protein/antibody production across mammalian/bacterial/insect/cell-free systems), CRISPR Gene Editing (OmniGuide RNA, Cas proteins, gRNA design tools, cell lines), IVT mRNA Services (mRNA synthesis, saRNA, circRNA, LNP formulations), Peptide Services (TurboTIDE express synthesis, custom peptides, peptide libraries via PepPower/PepHTS platforms, cGMP manufacturing, neoantigen peptides, GLP-1 agonists), Oligo Synthesis, Reagent Antibodies, and Cell Engineering (lentivirus/AAV packaging, stable cell lines). The company also maintains a catalog of reagent products including automated purification systems (AmMag Quatro), precast gels, antibodies, and ELISA kits. Quality systems include ISO 9001 certification and TQM protocols.

Differentiator

Problem solved

Functional benefit

Brands

• Bestzyme: Enzyme products brand
• ProBio
• PepPower
• TurboCHO
• FLASH Gene
• GenCRISPR
• TurboTIDE
• OmniGuide RNA
• ArgonShield
• CellPower
• GenSmart
• GenSpark
• GenCircle
• GenBrick
• GenEZ
• CytoSinct
• SurePAGE
• eBlot
• eStain
• AmMag
• AccuPep

Products and services

• Gene Synthesis Services
• Custom Peptide Synthesis
• TurboTIDE Peptide Synthesis
• TurboCHO Antibody Expression Service
• Protein Expression Services
• CRISPR Gene Editing Services
• IVT mRNA Services
• Research Grade AAV Packaging
• Lentivirus Packaging Service
• Peptide Library Service
• Neoantigen Peptide Service
• cGMP Peptide Synthesis
• GLP-1 Receptor Agonist Peptide Service
• Cosmetic Peptide Synthesis
• Catalog Peptides
• Oligo Synthesis Services
• Reagent Antibody Services
• DNA Mutant Library Services
• Cell Engineering Services
• Catalog Life Science Reagent Products
• AI Drug Discovery Solutions
• AmMag Quatro Purification Systems

Quantifiable outcome

• 99.99% gene synthesis delivery rate
• +5 more outcomes

Named customers11 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature10 records

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Twist Bioscience: Direct competitor in gene synthesis, oligonucleotide synthesis, and DNA data storage, offering NGS-targeted and synthetic biology product lines that compete head-to-head with GenScript's FLASH Gene and oligo services.
• Integrated DNA Technologies (IDT): Division of Danaher; major direct peer in custom oligonucleotides, gene synthesis, and CRISPR reagents, with overlapping academic and biopharma customer base and a global manufacturing footprint.
• Eurofins Genomics: Operates a comparable portfolio of gene synthesis, DNA sequencing, and synthetic biology services, targeting the same European and US academic/biotech customers as GenScript.
• Bio-Techne: Competes directly in recombinant proteins, antibodies, ELISA kits, and cell/gene therapy reagents — overlapping substantially with GenScript's catalog products and protein services lines.
• Bachem: Leading peptide API CDMO specializing in cGMP peptide manufacturing for GLP-1 and rare disease programs — directly competes with GenScript's emerging cGMP peptide business for clinical and commercial contracts.
• PolyPeptide Group: Global peptide CDMO serving pharma and cosmetic peptide markets; competes with GenScript's custom peptide and cGMP peptide API offerings, particularly in GLP-1 and specialty therapeutic peptides.
• GenScript Biotech (HKEX: 1548): Hong Kong-listed parent/affiliate operating the Bestzyme and ProBio subsidiaries referenced in the data; functions as a sister entity competing across the same gene, peptide, protein, and CDMO service categories.

Broad incumbents

• Thermo Fisher Scientific: Dominant life sciences tools incumbent with GeneArt gene synthesis, Invitrogen protein/antibody expression, and a global CDMO network — provides broader-portfolio competition to GenScript's research services and emerging CDMO ambitions.

Emerging players

• ATUM (formerly DNA2.0): Specialized gene synthesis and protein engineering CRO focused on synthetic biology and antibody discovery; addresses an overlapping but narrower customer set than GenScript.
• Synbio Technologies: China-based gene synthesis and synthetic biology services competitor; competes with GenScript on price in research-grade gene and oligo services, particularly in Asia-Pacific.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/genscript
• Facebookfacebook.com/genscriptcorp
• LinkedInlinkedin.com/company/genscript-corporation

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GenScript